Cargando…

Editorial: Real-World evidence in onco-hematological patients

Detalles Bibliográficos
Autores principales:	Vener, Claudia, Franchi, Matteo, Trama, Annalisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678046/ https://www.ncbi.nlm.nih.gov/pubmed/36419883 http://dx.doi.org/10.3389/fonc.2022.1060802

Ejemplares similares

Editorial: Digital health and real-world evidence in onco-hematological patients
por: Vener, Claudia, et al.
Publicado: (2023)

Late Mortality, Subsequent Malignant Neoplasms and Hospitalisations in Long-Term Survivors of Adolescent and Young Adult Hematological Cancers
por: Trama, Annalisa, et al.
Publicado: (2022)

Editorial: Real-world data and real-world evidence in hematologic malignancies
por: Malagola, Michele, et al.
Publicado: (2023)

Safety of switching between rituximab biosimilars in onco-hematology
por: Urru, Silvana A. M., et al.
Publicado: (2021)

Takotsubo Syndrome (TTS) in Onco-Hematologic Patients: Retrospective Analysis and Focus on the Correlation or Not With Anticancer Drugs. Case Reports and Review of the Literature
por: Monti, Manlio, et al.
Publicado: (2022)

Surgical Management of Rhinosinusitis in Onco-Hematological Patients
por: Di Girolamo, Stefano, et al.
Publicado: (2014)

Validity of Italian administrative healthcare data in describing the real-world utilization of infusive antineoplastic drugs: the study case of rituximab use in patients treated at the University Hospital of Siena for onco-haematological indications
por: Bartolini, Claudia, et al.
Publicado: (2023)

Clear Improvement in Real-World Chronic Myeloid Leukemia Survival: A Comparison With Randomized Controlled Trials
por: Vener, Claudia, et al.
Publicado: (2022)

Glucocorticoids and Antivirals for HBV Reactivation in Onco-Hematologic Patients.
por: Marzano, Alfredo, et al.
Publicado: (2010)

Two cases of paralitic ileus in onco-hematologic patients
por: Carraro, Francesca, et al.
Publicado: (2012)

Editorial: Reviews in hematologic malignancies
por: Saraceni, Francesco, et al.
Publicado: (2022)

Editorial: Real World Outcomes of Lymphoma From India
por: Kumar, Lalit, et al.
Publicado: (2022)

Top-ten infections in onco-hematological patients (2015-2017)
por: Camps, Isabel Ruiz, et al.
Publicado: (2019)

Health Related Quality of Life in Patients with Onco-hematological Diseases
por: La Nasa, Giorgio, et al.
Publicado: (2020)

Incidence, mortality, and survival of hematological malignancies in Northern Italian patients: an update to 2020
por: Mangone, Lucia, et al.
Publicado: (2023)

Editorial: Epidemiological trends in hematological malignancies
por: de Lima, Marcos, et al.
Publicado: (2023)

Targeting immune-onco-metabolism for precision cancer therapy
por: Pajai, Sakshi, et al.
Publicado: (2023)

Pediatric onco-hematological home care during COVID-19 pandemic
por: Amicucci, Matteo, et al.
Publicado: (2021)

Editorial: Rising Stars in Hematologic Malignancies 2021
por: Qian, Liren, et al.
Publicado: (2022)

Editorial: Linking cellular metabolism to hematological malignancies
por: He, Xiujing, et al.
Publicado: (2022)

Editorial: CAR T-Cell Therapies in Hematologic Tumors
por: Coscia, Marta, et al.
Publicado: (2020)

Editorial: Measurable residual disease in hematologic malignancies
por: Buccisano, Francesco, et al.
Publicado: (2023)

Editorial: Tumour microenvironment heterogeneity in hematological malignancies
por: Deaglio, Silvia, et al.
Publicado: (2023)

Editorial: Case reports in hematological malignancies: 2022
por: Antar, Ahmad, et al.
Publicado: (2023)

Onco-Esthetics Dilemma: Is There a Role for Electrocosmetic-Medical Devices?
por: Palmieri, Beniamino, et al.
Publicado: (2021)

The profile of the onco-hematology patient in the palliative care: 4 years of experience
por: Couto, Maria Eduarda, et al.
Publicado: (2019)

Reporting reimbursement price decisions for onco-hematology drugs in Spain
por: Elvira, David, et al.
Publicado: (2023)

Commentary: Onco-Esthetics Dilemma: Is There a Role for Electrocosmetic-Medical Devices?
por: Zdravkovic, Andrej, et al.
Publicado: (2021)

Editorial: COVID-19 and hematological malignancies: Volume II
por: Wilde, Lindsay, et al.
Publicado: (2022)

Editorial: The management of hematologic malignancies in lower-income countries
por: Ganesan, Prasanth, et al.
Publicado: (2023)

Editorial: Deciphering the bone marrow microenvironment in hematologic malignancies
por: Wobus, Manja, et al.
Publicado: (2023)

Editorial: Cancer treatment-related cardiovascular disease - real world data in cardio-oncology
por: Agarwala, Vivek, et al.
Publicado: (2023)

Obtaining Patient-Reported Outcomes Electronically With “OncoFunction” in Head and Neck Cancer Patients During Aftercare
por: Zebralla, Veit, et al.
Publicado: (2020)

Use of inflammatory molecules to predict the occurrence of fever in onco-hematological patients with neutropenia
por: Ribeiro, A.F. Tibúrcio, et al.
Publicado: (2013)

Virtual Reality Analgesia During Venipuncture in Pediatric Patients With Onco-Hematological Diseases
por: Atzori, Barbara, et al.
Publicado: (2018)

Cardio-onco-hematology patients’ management in the context of the current COVID-19 pandemic
por: Lorca, Rebeca, et al.
Publicado: (2020)

Immunogenicity profile after COVID-19 vaccination in patients with onco-hematological diseases
por: de Almeida, João Bosco, et al.
Publicado: (2023)

When Onco-Immunotherapy Meets Cold Atmospheric Plasma: Implications on CAR-T Therapies
por: Dai, Xiaofeng, et al.
Publicado: (2022)

Editorial: The Emerging Role for PP2A in Hematologic Malignancies
por: Ruvolo, Peter P.
Publicado: (2016)

Real-World Evidence in Glioblastoma: Stupp's Regimen After a Decade
por: Lakomy, Radek, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v97l9fgpsbeep07j05fh27grt1